The new website was created in response to client demands; due to an ever growing number of visitors accessing the main site via mobile devices. The mobile ready site enables users to store an Almac icon on their phone’s screen providing rapid access in just one click, enhanced resolution for all screens sizes, and a search facility enabling visitors to access any content from the full site.
“At Almac we are always looking to help clients with any requirements they have and by launching this new mobile website we are providing even greater accessibility for the significant number of people that view our services and locations through mobile devices. We are one of the first CDMO companies to invest in online technologies to respond to this growing need, providing up to date information on our global portfolio helping to facilitate real time decision making wherever you are.” said Philip Diamond, VP Corporate Market Development at Almac.
The new site can be visited on the following address: http://m.almacgroup.com/
About Almac:
The Almac Group provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS® technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors. The company employs over 3,300 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California.
Tristan Jervis
Managing Partner
Holborn Gate, 26 Southampton Buildings
London WC2A 1BP
Telephone: +44 (0)207 861 3838
Direct: +44 (0)207 861 3019
Fax: +44 (0)207 861 3839
E-mail: t.jervis@defacto.com
www.defacto.com
